Identification of HLA-A24-Restricted CTL Epitope from Cancer-Testis Antigen, NY-ESO-1, and Induction of a Specific Antitumor Immune Response

Clinical Cancer Research

Volumn 10, Issue 3, 2004, Pages 890-896

  Yamaguchi, Hiroshi ^a   Tanaka, Fumiaki ^a   Ohta, Mitsuhiko ^a   Inoue, Hiroshi ^a   Mori, Masaki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CANCER TESTIS ANTIGEN; HLA A24 ANTIGEN; HLA ANTIGEN CLASS 1; NY ESO 1 ANTIGEN; PEPTIDE; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CARCINOMA CELL; CASE REPORT; COMPUTER; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOTHERAPY; IN VITRO STUDY; JAPAN; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL;

ANTIGENS; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL LINE, TUMOR; CYTOKINES; DENDRITIC CELLS; DNA, COMPLEMENTARY; EPITOPES; HLA-A ANTIGENS; HUMANS; IMMUNOTHERAPY; LEUKOCYTES, MONONUCLEAR; MEMBRANE PROTEINS; NEOPLASMS; PEPTIDES; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 1042267230     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-1086-3     Document Type: Article

References (27)

1. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash. DC), 254: 1643-1647, 1991.
2. Jager, D., Jager, E., and Knuth, A. Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer. J. Clin. Pathol., 54: 669-674, 2001.
3. Boon, T., and Old, L. J. Cancer tumor antigens. Curr. Opin. Immunol., 9: 681-683, 1997.
4. Tanaka, F., Fujie, T., Tahara, K., Mori, M., Takesako, K., Sette, A., Celis, E., and Akiyoshi, T. Induction of antitumor cytotoxic T lymphocytes with a MAGE-3-encoded synthetic peptide presented by human leukocytes antigen-A24. Cancer Res., 57: 4465-4468, 1997.
5. Jager E., Chen, Y. T., Drijfhout, J. W., Karbach, J., Ringhoffer, M., Jager, D. Arand, M., Wada, H., Noguchi, Y., Stockert, E., Old, L. J., and Knuth A. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J. Exp. Med. 187: 265-270, 1998.
6. : Sadanaga, N., Nagashima, H., Mashino, K., Tahara, K., Yamaguchi, H., Ohta, M., Fujie, T., Tanaka, F., Inoue, H., Takesako, K., Akiyoshi, T., and Mori, M. Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas. Clin. Cancer Res., 7: 2277-2284, 2001.
7. Nishiyama, T., Tachibana, M., Horiguchi, Y., Nakamura, K., Ikeda, Y., Takesako, K., and Murai, M. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide. Clin. Cancer Res., 7: 23-31, 2001.
8. Chen, Y. T., Scanlan, M. J., Sahin, U., Tureci, O., Gure, A. O., Tsang, S., Williamson, B., Stockert, E., Pfreundschuh, M., and Old, L. J. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA, 94: 1914-1918, 1997.
9. Jungbluth, A. A., Antonescu, C. R., Busam, K. J., Iversen, K., Kolb, D., Coplan, K., Chen, Y. T., Stockert, E., Ladanyi, M., and Old, L. J. Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7. Int. J. Cancer, 94: 252-256, 2001.
10. Date, Y., Kimura, A., Kato, H., and Sasazuki, T. DNA typing of the HLA-A gene: population study and identification of four new alleles in Japanese. Tissue Antigens, 47: 93-101, 1996.
11. Schirle, M., Weinschenk, T., and Stevanovic, S. Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens. J. Immunol. Methods, 257: 1-16, 2001.
12. Tahara, K., Takesako, K., Sette, A., Celis, E., Kitano, S., and Akiyoshi, T. Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes. Clin. Cancer Res., 5: 2236-2241, 1999.
13. Nakao, M., Shichijo, S., Imaizumi, T., Inoue, Y., Matsunaga, K., Yamada, A., Kikuchi, M., Tsuda, N., Ohta, K., Takamori, S., Yamana, H., Fujita, H., and Itoh, K. Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL. J. Immunol., 164: 2565-2574, 2000.
14. Schumacher, T. N., Heemels, M. T., Neefjes, J. J., Kast, W. M., Melief, C. J., and Ploegh, H. L. Direct binding of peptide to empty MHC class 1 molecules on intact cells and in vitro. Cell, 62: 563-567, 1990.
15. Maeda, A., Ohguro, H., Nabeta, Y., Hirohashi, Y., Sahara, H., Maeda, T., Wada, Y., Sato, T., Yun, C., Nishimura, Y., Torigoe, T., Kuroki, Y., and Sato, N. Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome. Eur. J. Immunol., 31: 563-572, 2001.
16. Coulie, P. G., Brichard, V., Van Pel, A., Wolfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 180: 35-42, 1994.
17. Cheever, M. A., Disis, M. L., Bernhard, H., Gralow, J. R., Hand, S. L., Huseby, E. S., Qin, H. L., Takahashi, M., and Chen, W. Immunity to oncogenic proteins. Immunol. Rev., 145: 33-59, 1995.
18. Falk, K., Rotzschke, O., Stevanovic, S., Jung, G., and Rammensee, H. G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond.), 351: 290-296, 1991.
19. Celis, E., Tsai, V., Crimi, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Grey, H. M., Sette, A., and Serra, H. M. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA, 91: 2105-2109, 1994.
20. Parkhurst, M. R., Fitzgerald, E. B., Southwood, S., Sette, A., Rosenberg, S. A., and Kawakami, Y. Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). Cancer Res., 58: 4895-4901, 1998.
21. Stockert, E., Jager, E., Chen, Y. T., Scanlan, M. J., Gout, I., Karbach, J., Arand, M., Knuth, A., and Old, L. J. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J. Exp. Med., 187: 1349-1354, 1998.
22. Jager, E., Gnjatic, S., Nagata, Y., Stockert, E., Jager, D., Karbach, J., Neumann, A., Rieckenberg, J., Chen, Y. T., Ritter, G., Hoffman, E., Arand, M., Old, L. J., and Knuth, A. Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc. Natl. Acad. Sci. USA, 97: 12198-12203, 2000.
23. Falo, L. D., Jr., Colarusso, L. J., Benacerraf, B., and Rock, K. L. Serum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA, 89: 8347-8350, 1992.
24. Amoscato, A. A., Prenovitz, D. A., and Lotze, M. T. Rapid extracellular degradation of synthetic class I peptides by human dendritic cells. J. Immunol., 161: 4023-4032, 1998.
25. Kessler, J. H., Beekman, N. J., Bres-Vloemans, S. A., Verdijk, P., van Veelen, P. A., Kloosterman-Joosten, A. M., Vissers, D. C., ten Bosch, G. J., Kester, M. G., Sijts, A., Wouter Drijfhout, J., Ossendorp, F., Offringa, R., and Melief, C. J. Efficient identification of novel HLA-A(*) 0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis. J. Exp. Med., 193: 73-88, 2001.
26. Schmitz, M., Bornhauser, M., Ockert, D., and Rieber, E. P. Cancer immunotherapy: novel strategies and clinical experiences. Trends Immunol., 23: 428-429, 2002.
27. Mashino, K., Sadanaga, N., Tanaka, F., Yamaguchi, H., Nagashima, H., Inoue, H., Sugimachi, K., and Mori, M. Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas. Br. J. Cancer, 85: 713-720, 2001.